A dual chamber pacemaker paces the atrium and ventricle. A biventricular pacemaker paces both ventricles. An implantable cardioverter-defibrillator can function as a pacemaker would. In addition, if it detects ventricular tachycardia or fibrillation, it sends out a shock to reset the heart to a normal rhythm.
In over half of the cases, however, sudden cardiac arrest occurs without prior symptoms. Therefore prevention and risk diagnosis are key targets in this area. Epidemiological studies have suggested that genetic factors contribute to sudden cardiac death, however, only a few genes have been identified. Now, a study from researchers at St. Marien-Hospital Mülheim has identified a gene associated with sudden cardiac death in the general population using an implantable cardioverter…
Cardiac Catheterization and Stenting - A coronary catheterization is a minimally invasive procedure to access the coronary circulation and blood filled chambers of the heart using a catheter. It is performed for both diagnostic and interventional (treatment) purposes.
Satish Tiyyagura, MD, FACC, Director, Electrophysiology Laboratory, St. Joseph's Regional Medical Center, is among the first in New Jersey to implant the newly FDA-approved mini implantable cardioverter defibrillator (ICD), an automated treatment of life-threatening ventricular arrhythmias. To learn more about the procedure and ICD, view the video on our website below!
Implantable cardioverter-defibrillator (ICD) is a small battery-powered electrical impulse generator that is implanted in patients who are at risk of sudden cardiac death due to ventricular fibrillation and ventricular tachycardia. It detects cardiac arrhythmia and correct it by delivering a jolt of electricity. Ability to revert ventricular fibrillation. Can include both atrial and ventricular arrhythmias. Can perform biventricular pacing for congestive heart failure or bradycardia.
implantable cardioverter-defibrillator (ICD) is a small battery-powered electrical impulse generator which is implanted in patients who are at risk of sudden cardiac death due to ventricular fibrillation and ventricular tachycardia